Genomic Vision Logo

Genomic Vision

Develops DNA analysis tools using Molecular Combing for genetic research and diagnostics.

GV | PA

Overview

Corporate Details

ISIN(s):
FR0011799907
LEI:
969500UXJNBY1C8Y8471
Country:
France
Address:
80 RUE DES MEUNIERS, 92220 BAGNEUX
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Genomic Vision is a biotechnology company that develops advanced tools, services, and diagnostic solutions for genetic analysis. The company specializes in visualizing and characterizing individual DNA molecules through its proprietary Molecular Combing Technology, a nanotechnology platform for highly accurate DNA analysis. Its products and services are utilized in the research and diagnosis of cancer and inherited genetic diseases, as well as in drug discovery and biomanufacturing for cell characterization. Genomic Vision aims to establish new standards for DNA analysis to improve disease monitoring and treatment strategies.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-11-17 18:00
Legal Proceedings Report
Inside Information / Other news releases
English 171.1 KB
2023-11-17 18:00
Legal Proceedings Report
Informations privilégiées / Autres communiqués
French 168.7 KB
2023-11-14 18:00
Legal Proceedings Report
Inside Information / News release on accounts, results
English 183.9 KB
2023-11-14 18:00
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
French 182.8 KB
2023-11-08 18:38
Declaration of Voting Results & Voting Rights Announcements
Informations privilégiées / Autres communiqués
French 79.6 KB
2023-11-07 18:00
Board/Management Information
Informations privilégiées / Autres communiqués
French 165.9 KB
2023-11-03 18:00
Legal Proceedings Report
Inside Information / Other news releases
English 133.1 KB
2023-11-03 18:00
Legal Proceedings Report
Informations privilégiées / Autres communiqués
French 134.9 KB
2023-11-02 07:00
Earnings Release
Informations privilégiées / Autres communiqués
French 166.5 KB
2023-11-02 07:00
Environmental & Social Information
Inside Information / Other news releases
English 165.6 KB
2023-10-24 18:00
Regulatory News Service
Informations privilégiées / Autres communiqués
French 123.8 KB
2023-10-24 18:00
Regulatory News Service
Inside Information / Other news releases
English 122.3 KB
2023-10-19 09:29
Declaration of Voting Results & Voting Rights Announcements
Franchissement de seuils
French 272.4 KB
2023-10-18 14:49
Major Shareholding Notification
Franchissement de seuils
French 272.6 KB
2023-10-12 07:00
Legal Proceedings Report
Informations privilégiées / Autres communiqués
French 157.0 KB

Automate Your Workflow. Get a real-time feed of all Genomic Vision filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Genomic Vision via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
OPTIBIOTIX HEALTH PLC Logo
Develops microbiome-modulating ingredients and supplements to manage chronic lifestyle diseases.
United Kingdom OPTI
OXFORD BIODYNAMICS PLC Logo
Develops precision blood tests using 3D genomics for cancer diagnosis and therapy guidance.
United Kingdom OBD
Pharnext Logo France ALPHA
PHYSIOMICS PLC Logo
De-risks oncology drug development for pharma/biotech using modeling and simulation.
United Kingdom PYC
PILA PHARMA AB Logo
Clinical-stage biopharma developing a first-in-class oral drug for diabetes and obesity.
Sweden PILA
POOLBEG PHARMA PLC Logo
AI-led biopharma developing drugs for high-need diseases like CRS and metabolic disorders.
United Kingdom POLB
PROTEOME SCIENCES PLC Logo
CRO providing proteomics services & TMT® tags to biopharma for drug discovery & biomarkers.
United Kingdom PRM
PROVEXIS PLC Logo
Develops & licenses Fruitflow®, a patented ingredient for heart health in food & supplements.
United Kingdom PXS
Develops uncopiable atomic fingerprints for anti-counterfeiting, verifiable by smartphone.
United Kingdom N/A
QUANTUM BLOCKCHAIN TECHNOLOGIES PLC Logo
R&D firm using AI and quantum computing to create efficient technologies for Bitcoin mining.
United Kingdom QBT

Talk to a Data Expert

Have a question? We'll get back to you promptly.